Jiten Pant
CEO / Founder
NOBiotics
This company develops nitric oxide-based biotech products to improve patient outcomes in urology, cardiac health, and wound healing. Their products leverage nitric oxide's therapeutic properties to address unmet needs in these specific medical areas.
- Biotechnology
Updated 5 months ago
Funding
Funding not disclosed
across 1 round
NS
RoundDateAmountValuationInvestors
Founders
Product
Problem
Current treatments for bacterial infections and methods for promoting tissue regeneration in urology, cardiac health, and wound healing often face limitations in efficacy and biocompatibility. Traditional approaches may not fully address the underlying physiological challenges or promote optimal patient outcomes.
Solution
NOBiotics develops biomedical technologies and products leveraging the therapeutic properties of nitric oxide (NO) to address unmet needs in urology, cardiac health, and wound healing. The company's focus is on creating innovative solutions that enhance patient care through advanced biotherapeutics, biomedical technology, and cell and gene therapies. By harnessing NO's biological effects, NOBiotics aims to improve treatment efficacy, accelerate healing processes, and enhance overall health outcomes. Their products are developed with scientific rigor and a commitment to improving lives, offering solutions for combating bacterial infections, improving biomedical research accuracy, and advancing cell and gene therapy applications.
Target Audience
NOBiotics' products target healthcare professionals and patients in need of advanced therapies and solutions in urology, cardiac health, wound healing, and biomedical research.
Features
- Advanced biotherapeutics utilizing nitric oxide to combat bacterial infections
- Biomedical technology products designed to improve the accuracy and precision of biomedical research
- Innovative cell and gene therapies developed with a focus on patient outcomes
- Development of wound dressings and patches with clot-forming and antibacterial properties
- Expertise in creating tunable nitric oxide release mechanisms for biomedical applications
- Research-driven approach with publications in leading peer-reviewed journals